RESEARCH TRIANGLE PARK, N.C. – February 18, 2005 – Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and the University of North Carolina at Chapel Hill today announced the creation of a new alliance for clinical research.
The alliance will give more patients and investigators access to clinical research, help develop new clinical investigators, improve efficiency in the clinical trial process, and allow Quintiles and UNC to collaborate on industry-sponsored and federally sponsored clinical trials.
"This is a highly creative, innovative partnership between a leading clinical research organization and a leading medical school, bringing together our individual skills and expertise," said William L. Roper, M.D., MPH, dean of the UNC-CH School of Medicine and CEO of UNC Health Care. "We believe this will serve as a model of how a CRO can help an academic medical center increase its efficiency and capacity for effective clinical trials work, and how a medical school can bring added value and expertise to a CRO."
As part of the alliance, UNC will establish a clinical research unit that will provide centralized support for clinical research at UNC-Chapel Hill. Quintiles will provide Good Clinical Practice training for staff at the clinical research unit.
"Working with UNC is important for Quintiles because it will provide real benefits for our customers and for patients as well, and it also underscores the innovative research going on at UNC," said Dennis Gillings, Ph.D., Chairman and CEO of Quintiles Transnational. "The clinical research unit will help UNC and Quintiles conduct more clinical trials. Drug development always is working against the clock, and I believe this alliance will help us gain precious days and weeks in getting new medicines to patients."
To help establish the clinical trial unit, Quintiles is providing a $600,000 research grant over two years to UNC. The grant will help provide new opportunities to patients to participate in clinical trials and gain access to the latest experimental treatments available.
Quintiles helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles has offices in 50 countries and is the world's leading pharmaceutical services organization. For more information visit the company's Web site at www.quintiles.com.
About UNC School of Medicine
Established in 1879, UNC is the oldest medical school in North Carolina. The School's mission is to educate students and professionals of the health and biomedical sciences, to conduct scholarly investigation in biomedical, behavioral, and social sciences, and to render service to the people and institutions of the state, the region, the nation, and, as appropriate, throughout the world. Today, UNC's School of Medicine maintains a position of national leadership. UNC is one of only a handful of leading medical schools nationally both in funding for biomedical research and in the training of primary care physicians.